Skip to Content
Brain SciencesBrain Sciences
  • Case Report
  • Open Access

15 June 2020

5 Pages

Familial Hemiplegic Migraine with an ATP1A4 Mutation: Clinical Spectrum and Carbamazepine Efficacy

,
,
,
and
1
Clinic of Child and Adolescent Neuropsychiatry, Department of Medicine, Surgery and Dentistry, Medical School University of Salerno, 84100 Salerno, Italy
2
Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90133 Palermo, Italy
*
Author to whom correspondence should be addressed.
This article belongs to the Special Issue Neurological Diseases in Children

Abstract

An Italian family with familial hemiplegic migraine (FHM) with the absence of mutations in the known genes associated with this disorder, namely ATP1A2, ATP1A3, CACNA1A, and SCN1A, has recently been reported. Soon afterward, whole exome sequencing allowed the identification of the carrier status of a heterozygous ATP1A4 mutation c.1798 C >T, in four affected members of this family. Here we compare the clinical symptoms of the affected family members with those from the other FHM families linked to mutations in the known genes associated with this disorder. A further two-year follow-up, including clinical response to carbamazepine administered to the proband and the maternal grandmother due to a worsening of the migraine symptoms, is reported. The clinical condition of the proband’s brother, carrying the same mutation and suffering from congenital ventricular and supraventricular extrasystoles, isdiscussed as well.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.